SubHero Banner
Text

Azstarys (serdexmethylphenidate/dexmethylphenidate) – New drug approval

March 2, 2021 - KemPharm announced the FDA approval of Azstarys (serdexmethylphenidate/dexmethylphenidate), for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older.

Download PDF